Stage II Grade 3 Non-Contiguous Follicular Lymphoma Active Not Recruiting Phase 2 Trials for Lenalidomide (DB00480)

IndicationStatusPhase
DBCOND0031238 (Stage II Grade 3 Non-Contiguous Follicular Lymphoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01145495Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin LymphomaTreatment